You are here

  • Home
  • Archive
  • Volume 13, Issue 7
  • Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

Citation Tools

Article menu

Download PDFPDF

Cardiovascular medicine
Protocol
Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Huang Z, Zhuang X, Zhang S, et al
Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial
BMJ Open 2023;13:e072541. doi: 10.1136/bmjopen-2023-072541